Literature DB >> 26407270

Failure of Syndrome-Based Diarrhea Management Guidelines to Detect Shigella Infections in Kenyan Children.

P B Pavlinac1,2, D M Denno3,2,4, G C John-Stewart1,3,2,5, F M Onchiri1, J M Naulikha3,6, E A Odundo7, C E Hulseberg7, B O Singa6, L E Manhart1,2, J L Walson1,3,2,5.   

Abstract

BACKGROUND: Shigella is a leading cause of childhood diarrhea mortality in sub-Saharan Africa. Current World Health Organization guidelines recommend antibiotics for children in non cholera-endemic areas only in the presence of dysentery, a proxy for suspected Shigella infection.
METHODS: To assess the sensitivity and specificity of the syndromic diagnosis of Shigella-associated diarrhea, we enrolled children aged 6 months to 5 years presenting to 1 of 3 Western Kenya hospitals between November 2011 and July 2014 with acute diarrhea. Stool samples were tested using standard methods for bacterial culture and multiplex polymerase chain reaction for pathogenic Escherichia coli. Stepwise multivariable logit models identified factors to increase the sensitivity of syndromic diagnosis.
RESULTS: Among 1360 enrolled children, median age was 21 months (interquartile range, 11-37), 3.4% were infected with human immunodeficiency virus, and 16.5% were stunted (height-for-age z-score less than -2). Shigella was identified in 63 children (4.6%), with the most common species being Shigella sonnei (53.8%) and Shigella flexneri (40.4%). Dysentery correctly classified 7 of 63 Shigella cases (sensitivity, 11.1%). Seventy-eight of 1297 children without Shigella had dysentery (specificity, 94.0%). The combination of fecal mucous, age over 23 months, and absence of excessive vomiting identified more children with Shigella-infection (sensitivity, 39.7%) but also indicated antibiotics in more children without microbiologically confirmed Shigella (specificity, 82.7%).
CONCLUSIONS: Reliance on dysentery as a proxy for Shigella results in the majority of Shigella-infected children not being identified for antibiotics. Field-ready rapid diagnostics or updated evidence-based algorithms are urgently needed to identify children with diarrhea most likely to benefit from antibiotic therapy.
© The Author 2015. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Shigella; algorithms for diarrhea; antibiotic indication; dysentery; pediatric diarrhea; syndromic

Mesh:

Year:  2015        PMID: 26407270      PMCID: PMC5181358          DOI: 10.1093/jpids/piv037

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  37 in total

1.  Effects of Shigella-, Campylobacter- and ETEC-associated diarrhea on childhood growth.

Authors:  Gwenyth Lee; Maribel Paredes Olortegui; Pablo Peñataro Yori; Robert E Black; Laura Caulfield; Cesar Banda Chavez; Eric Hall; William K Pan; Rina Meza; Margaret Kosek
Journal:  Pediatr Infect Dis J       Date:  2014-10       Impact factor: 2.129

2.  Changing species distribution and antimicrobial susceptibility pattern of Shigella over a 29-year period (1980-2008).

Authors:  F Khatun; A S G Faruque; J L Koeck; P Olliaro; P Millet; N Paris; M A Malek; M A Salam; S Luby
Journal:  Epidemiol Infect       Date:  2010-05-18       Impact factor: 2.451

3.  Death in shigellosis: incidence and risk factors in hospitalized patients.

Authors:  M L Bennish; J R Harris; B J Wojtyniak; M Struelens
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

4.  Epidemiology of postshigellosis persistent diarrhea in young children.

Authors:  F Ahmed; M Ansaruzzaman; E Haque; M R Rao; J D Clemens
Journal:  Pediatr Infect Dis J       Date:  2001-05       Impact factor: 2.129

5.  Predictors of mortality in children hospitalized with dysentery in Harare, Zimbabwe.

Authors:  K J Nathoo; J E Porteous; S Siziya; M Wellington; E Mason
Journal:  Cent Afr J Med       Date:  1998-11

6.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

7.  Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge.

Authors:  David N Taylor; Robin McKenzie; Anna Durbin; Colleen Carpenter; Christophe B Atzinger; Robert Haake; A Louis Bourgeois
Journal:  Clin Infect Dis       Date:  2006-03-22       Impact factor: 9.079

8.  Characteristics of children with Shigella encephalopathy: experience from a large urban diarrhea treatment center in Bangladesh.

Authors:  Mohammod Jobayer Chisti; Abu Syed Golam Faruque; Wasif Ali Khan; Sumon Kumar Das; Mir Borhan Zabed; Mohammed Abdus Salam
Journal:  Pediatr Infect Dis J       Date:  2010-05       Impact factor: 2.129

9.  Treatment of diarrhea in young children: results from surveys on the perception and use of oral rehydration solutions, antibiotics, and other therapies in India and Kenya.

Authors:  Greg Zwisler; Evan Simpson; Melissa Moodley
Journal:  J Glob Health       Date:  2013-06       Impact factor: 4.413

Review 10.  The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials.

Authors:  Ethan K Gough; Erica E M Moodie; Andrew J Prendergast; Sarasa M A Johnson; Jean H Humphrey; Rebecca J Stoltzfus; A Sarah Walker; Indi Trehan; Diana M Gibb; Rie Goto; Soraia Tahan; Mauro Batista de Morais; Amee R Manges
Journal:  BMJ       Date:  2014-04-15
View more
  16 in total

1.  Effect of early life antibiotic use on serologic responses to oral rotavirus vaccine in the MAL-ED birth cohort study.

Authors:  Denise T St Jean; Elizabeth T Rogawski McQuade; Jessie K Edwards; Peyton Thompson; James Thomas; Sylvia Becker-Dreps
Journal:  Vaccine       Date:  2022-03-25       Impact factor: 4.169

Review 2.  Interventions to reduce post-acute consequences of diarrheal disease in children: a systematic review.

Authors:  Patricia B Pavlinac; Rebecca L Brander; Hannah E Atlas; Grace C John-Stewart; Donna M Denno; Judd L Walson
Journal:  BMC Public Health       Date:  2018-02-01       Impact factor: 3.295

Review 3.  The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management.

Authors:  Margaret Mokomane; Ishmael Kasvosve; Emilia de Melo; Jeffrey M Pernica; David M Goldfarb
Journal:  Ther Adv Infect Dis       Date:  2017-12-07

4.  Multidrug-resistant enteric pathogens in older children and adults with diarrhea in Bangladesh: epidemiology and risk factors.

Authors:  Stephanie C Garbern; Tzu-Chun Chu; Monique Gainey; Samika S Kanekar; Sabiha Nasrin; Kexin Qu; Meagan A Barry; Eric J Nelson; Daniel T Leung; Christopher H Schmid; Nur H Alam; Adam C Levine
Journal:  Trop Med Health       Date:  2021-05-10

5.  Use of antibiotics in children younger than two years in eight countries: a prospective cohort study.

Authors:  Elizabeth T Rogawski; James A Platts-Mills; Jessica C Seidman; Sushil John; Mustafa Mahfuz; Manjeswori Ulak; Sanjaya K Shrestha; Sajid Bashir Soofi; Pablo Penataro Yori; Estomih Mduma; Erling Svensen; Tahmeed Ahmed; Aldo Am Lima; Zulfiqar A Bhutta; Margaret N Kosek; Dennis R Lang; Michael Gottlieb; Anita Km Zaidi; Gagandeep Kang; Pascal O Bessong; Eric R Houpt; Richard L Guerrant
Journal:  Bull World Health Organ       Date:  2016-11-03       Impact factor: 9.408

6.  Health worker knowledge of Integrated Disease Surveillance and Response standard case definitions: a cross-sectional survey at rural health facilities in Kenya.

Authors:  Mitsuru Toda; Dejan Zurovac; Ian Njeru; David Kareko; Matilu Mwau; Kouichi Morita
Journal:  BMC Public Health       Date:  2018-01-17       Impact factor: 3.295

7.  Impact of Childhood Nutritional Status on Pathogen Prevalence and Severity of Acute Diarrhea.

Authors:  Kirkby D Tickell; Patricia B Pavlinac; Grace C John-Stewart; Donna M Denno; Barbra A Richardson; Jaqueline M Naulikha; Ronald K Kirera; Brett E Swierczewski; Benson O Singa; Judd L Walson
Journal:  Am J Trop Med Hyg       Date:  2017-11       Impact factor: 2.345

Review 8.  Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis.

Authors:  Kirkby D Tickell; Rebecca L Brander; Hannah E Atlas; Jeffrey M Pernica; Judd L Walson; Patricia B Pavlinac
Journal:  Lancet Glob Health       Date:  2017-12       Impact factor: 38.927

9.  A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.

Authors:  Christina W Obiero; Augustin G W Ndiaye; Antonella Silvia Sciré; Bonface M Kaunyangi; Elisa Marchetti; Ann M Gone; Lena Dorothee Schütte; Daniele Riccucci; Joachim Auerbach; Allan Saul; Laura B Martin; Philip Bejon; Patricia Njuguna; Audino Podda
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

10.  Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial.

Authors:  Jeffrey M Pernica; Andrew P Steenhoff; Margaret Mokomane; Banno Moorad; Kwana Lechiile; Marek Smieja; Loeto Mazhani; Ji Cheng; Matthew S Kelly; Mark Loeb; Ketil Stordal; David M Goldfarb
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.